Hostname: page-component-76fb5796d-25wd4 Total loading time: 0 Render date: 2024-04-27T01:37:39.133Z Has data issue: false hasContentIssue false
  • English
  • Français

Blood Platelets and Psychiatry

Published online by Cambridge University Press:  29 January 2018

Iain C. Campbell
Get access Rights & Permissions [Opens in a new window]

Extract

Blood platelets appear to have a somewhat schizoid existence. Haematologically they are intimately connected with the process of clot formation (for review, see Zucker, 1980) and, at least from a research standpoint, this aspect of their being is largely separate from their use as models of monoaminergic neurones (for reviews, see Maynert and Isaac, 1968; Abrams and Solomon, 1969; Lingjaerde, 1977; Stahl, 1977; Pletscher, 1978).

Type
Comments
Information
The British Journal of Psychiatry , Volume 138 , Issue 1 , January 1981 , pp. 78 - 80
Copyright
Copyright © The Royal College of Psychiatrists 

Access options

Get access to the full version of this content by using one of the access options below. (Log in options will check for institutional or personal access. Content may require purchase if you do not have access.)

References

Abrams, W. B. & Solomon, H. M. (1969) The human platelet as a pharmacologic model for the adrenergic neuron: the uptake and release of norepinephrine. Clinical Pharmacology and Therapeutics, 10, 702–709.Google Scholar
Belmaker, R. Murphy, D. L. & Wyatt, R. J. (1974) Human platelet monoamine oxidase changes during the menstrual cycle. Archives of General Psychiatry, 31, 557–560.Google Scholar
Berneis, K. H. Da Prada, M. & Pletscher, A. (1969) Micelle formation between 5-hydroxytryptamine and adenosine triphosphate in platelet storage organelles. Science, 165, 913–914.CrossRefGoogle ScholarPubMed
Boullin, D. & Elliott, J. M. (1979) Binding of [3H] dehydroergocryptine to α-adrenoceptors on intact human platelets. British Journal of Pharmacology and Chemotherapy, 66, 89P.Google Scholar
Briley, M. S. Raisman, R. & Langer, S. Z. (1979) Human platelets possess high affinity binding sites for [3H]-imipramine. European Journal of Pharmacology, 58, 347–348.CrossRefGoogle ScholarPubMed
Campbell, I. C. & Todrick, A. (1970) Plasma protein binding of tricyclic antidepressant drugs. Journal of Pharmacy and Pharmacology, 22, 226–227.Google Scholar
Campbell, I. C. & Todrick, A. (1973) On the pharmacology and biochemistry of the amine uptake mechanism in human blood platelets. British Journal of Pharmacology, 49, 279–287.Google Scholar
Campbell, I. C. & Todrick, A. (1976) Effects of 4-Methyl-Ethyl tyramine and 4, α-dimethyl tyramine and tetrabenazine on the release and uptake of 5-hydroxytryptamine by human blood platelets in vitro. Life Sciences, 18, 1091–1098.CrossRefGoogle Scholar
Campbell, I. C. Marangos, P. J. Murphy, D. L. & Pearse, A. G. E. (1980) Neurone-specific enolase (NSE) in human blood platelets: implications for the neuronal model. In Proceedings of the 12th Collegium internationale neuropsychopharmacologicum (ed. Lingjaerde, O.). Oxford: Pergamon Press.Google Scholar
Carlsson, A. Corrodi, H. Fuxe, K. & Hokfelt, T. (1969) Effect of some antidepressant drugs on the depletion of intraneuronal brain 5-hydroxytryptamine stores caused by 4-methyl-α-ethyl-metatyramine. European Journal of Pharmacology, 5, 357–366.CrossRefGoogle Scholar
Coppen, A. Swade, C. & Wood, K. (1980) Lithium restores abnormal platelet 5-HT transport in patients with affective disorders. British Journal of Psychiatry, 136, 235–238.Google Scholar
Da Prada, M. Pletscher, A. Transer, J. P. & Knuchell, H. (1967) Subcellular localization of 5-hydroxytryptamine and histamine in blood platelets. Nature, 216, 1315–1317.Google Scholar
Donnelly, C. H. & Murphy, D. L. (1977) Substrate and inhibitor-related characteristics of human platelet monoamine oxidase. Biochemical Pharmacology, 26, 852–858.Google Scholar
Elliott, J. M. & Grahame-Smith, D. G. Evidence for a single type of α-adrenoceptor on human platelets. British Journal of Pharmacology (in press).Google Scholar
Garrick, N. A. Redmond, D. E. Jr. & Murphy, D. L. (1979) Primate-rodent monoamine oxidase differences in Monoamine Oxidase, Structure, Function and Altered Functions (eds. Singer, T. P. Von Korff, R. W. and Murphy, D. L.). New York: Academic Press, 351–360.Google Scholar
Gentil, V. Greenwood, M. H. & Lader, M. H. (1975) The effect of adrenaline on human platelet monoamine oxidase. Psychopharmacologia (Berlin), 44, 187–194.Google Scholar
Grant, J. A. & Scrutton, M. C. (1979) Novel α2-adrenoceptors primarily responsible for inducing human platelet aggregation. Nature, 277, 659–661.Google Scholar
Haier, R. J. Buchsbaum, M. S. Murphy, D. L. Gottesman, I. I. & Coursey, R. D. (1980) Psychiatric vulnerability, monoamine oxidase and the average evoked potential. Archives of General Psychiatry, 37, 340–345.CrossRefGoogle ScholarPubMed
Hoffman, B. B. deLean, A. Wood, C. L. Schocken, D. D. & Lefkowitz, R. J. (1979) Alpha-adrenergic receptor sub-types: quantitative assessment by ligand binding. Life Sciences, 24, 1739–1745.Google Scholar
Johnstone, J. P. (1968) Some observations upon a new inhibitor of monoamine oxidase in brain tissue. Biochemical Pharmacology, 17, 1285–1297.Google Scholar
Lingjaerde, O. (1977) Platelet uptake and storage of serotonin in Serotonin in Health and Disease, 4 (ed. Essman, W. B.), 139–199. New York: Spectrum.Google Scholar
Marangos, P. J. Campbell, I. C. Schmechel, D. E. Murphy, D. L. & Goodwin, F. K. (1980) Blood platelets contain a neurone-specific enolase subunit. Journal of Neurochemistry, 34, 1254–1258.Google Scholar
Marshall, E. F. Stirling, G. S. Tait, A. C. & Todrick, A. (1960) The effect of iproniazid and imipramine on the blood platelet 5-hydroxytryptamine level in man. British Journal of Pharmacology and Chemotherapy, 15, 35–41.Google Scholar
Maynert, E. W. & Isaac, L. (1968) Uptake and binding of serotonin by the platelet and its granules. Advances in Pharmacology, 6A, 113–122.Google Scholar
Murphy, D. L. (1978) Substrate-selective monoamine oxidases—inhibitor, tissue, species and functional differences. Biochemical Pharmacology, 27, 1889–1894.CrossRefGoogle ScholarPubMed
Murphy, D. L. & Weiss, R. (1972) Reduced monoamine oxidase activity in blood platelets from bipolar depressed patients. American Journal of Psychiatry, 128, 1351–1357.Google Scholar
Nies, A. Robinson, D. S. Lamborn, K. R. & Lampert, R. P. (1973) Genetic control of platelet and plasma monoamine oxidase activity. Archives of General Psychiatry, 28, 834–838.CrossRefGoogle ScholarPubMed
Paasonen, M. K. (1968) Platelet 5-hydroxytryptamine as model in pharmacology. Annates medicinae experimentalis et biologiae Fenniae, 46, 416–422.Google Scholar
Paul, S. Rehavi, M. Skolnick, P. & Goodwin, F. K. (1980) Demonstration of specific high affinity binding sites for [3H]-imipramine in human brain and platelet. Proceedings of the 12th Collegium internationale neuropsychopharmacologicum (Abstract), 277.Google Scholar
Pearse, A. G. E. (1968) Common cytrochemical and structural characteristics of cells producing polypeptide hormones (the APUD series) and their relevance to thyroid and ultimobronchial C cells and calcitonia. Proceedings of the Royal Society, London, (Biological Sciences), 170, 71–80.Google Scholar
Pearse, A. G. E. (1977) The diffuse neuroendocrine system and the ‘common peptides’. In Molecular Endocrinology (eds. MacIntyre, and Szelke, ). Amsterdam: Elsevier, 309–323.Google Scholar
Pearse, A. G. E. (1979) The endocrine division of the nervous system: a concept and its verification. In Molecular Endocrinology (eds. MacIntyre, and Szelke, ). Amsterdam: Elsevier, 4–17.Google Scholar
Pletscher, A. (1978) Platelets as models for monoaminergic neurones in Essays in Neurochemistry (eds. Youdim, M. B. H. W. Lovenberg, Sharman, D. F. and Lagnado, J. R.). 49–103. New York: John Wiley.Google Scholar
Rand, M. & Reid, G. (1951) Source of serotonin in blood. Nature, 168, 384–385.Google Scholar
Rehavi, M. Paul, S. M. Skolnick, P. & Goodwin, F. K. (1980) Demonstration of specific high affinity binding sites for [3H] imipramine in human brain. Life Sciences, 26, 2273–2279.Google Scholar
Reveley, M. A. Gurling, H. Glass, I. Glover, V. and Sandler, M. Platelet GABA-transaminase and monoamine oxidase in schizophrenia. Neuropharmacology (in press).Google Scholar
Sandler, M. & Reynolds, G. R. (1976) Does phenyl-ethylamine cause schizophrenia? Lancet, i, 70–71.Google Scholar
Stahl, S. (1977) The human platelet. Archives of General Psychiatry, 34, 509–516.CrossRefGoogle ScholarPubMed
Sulser, F. & Robinson, S. E. (1978) Clinical implications of pharmacological differences among antipsychotic drugs (with particular emphasis on biochemical central synaptic adrenergic mechanisms. In Psychopharmacology: A Generation of Progress (eds. Lipton, M. A. DiMascio, A. and Killam, K. F.). New York: Raven Press.Google Scholar
Todrick, A. & Tait, A. C. (1969) The inhibition of human platelet 5-hydroxytryptamine uptake by tricyclic antidepressive drugs: the relation between structure and function. Journal of Pharmacy and Pharmacology, 21, 751–762.Google Scholar
Tuomisto, J. & Tukianen, E. (1976) Decreased uptake of 5-hydroxytryptamine on blood platelets from depressed patients. Nature, 262, 596–598.Google Scholar
White, H. L. (1979) 4-aminobutyrate: 2-oxoglutarate aminotransferase in blood platelets. Science, 205, 696–698.Google Scholar
White, H. L. & Sato, T. L. (1978) Gaba-transaminases of human brain and peripheral tissues—kinetic and molecular properties. Journal of Neurochemistry, 31, 41–47.CrossRefGoogle ScholarPubMed
Winblad, B. Gottfries, C-G., Oreland, L. & Wiberg, A. (1979) Monoamine oxidase in platelets and brains of non-psychiatric and non-neurological geriatric patients. Medical Biology, 57, 129–132.Google Scholar
Wyatt, R. J. Potkin, S. G. & Murphy, D. L. (1979) Platelet monoamine oxidase activity in schizophrenia: a review of the data. American Journal of Psychiatry 136, 377–385.Google Scholar
Zucker, M. B. (1980) The functioning of blood platelets. Scientific American, 242, 86–103.Google Scholar
Zarifian, E. Raisman, R. Sechter, D. Briley, M. & Langer, S. Z. (1980) Specific [3H]-imipramine binding in human platelets: differences between depressed patients and healthy volunteers. Proceedings of the 12th Collegium internationale neuropsychopharmacologicum (Abstract), 367.Google Scholar
Submit a response

eLetters

No eLetters have been published for this article.